Timothy Penn

Timothy Penn

Auto-generated profile, based on publicly available information

Timothy Penn

Flinders University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2020 in Cells
Verified
Journal Article
Open access
PDF file
VCVanessa Conn
Vanessa Conn
Marta GabryelskaMarta Gabryelska
Marta Gabryelska
SMShashikanth Marri
Shashikanth Marri
BSBrett Stringer
Brett Stringer
RORebecca Ormsby
Rebecca Ormsby
Simon ConnSimon Conn
Simon Conn
High-throughput RNA sequencing (RNA-seq) and dedicated bioinformatics pipelines have synergized to identify an expansive repertoire of unique circular RNAs (circRNAs), exceeding 100,000 variants. While the vast majority of these circRNAs comprise canonical exonic and intronic sequences, microexons (MEs)—which occur in 30% of functional mRNA transcripts—have been entirely overlooked. CircRNAs which contain these known MEs (ME-circRNAs) could be identified with commonly utilized circRNA prediction pipelines, CIRCexplorer2 and CIRI2, but were not previously recognized as ME-circRNAs. In addition, when employing a bespoke bioinformatics pipeline for identifying RNA chimeras, called Hyb, we could also identify over 2000 ME-circRNAs which contain novel MEs at their backsplice junctions, that are uncalled by either CIRCexplorer2 or CIRI2. Analysis of circRNA-seq datasets from gliomas of varying clinical grades compared with matched control tissue has shown circRNAs have potential as prognostic markers for stratifying tumor from healthy tissue. Furthermore, the abundance of microexon-containing circRNAs (ME-circRNAs) between tumor and normal tissues is correlated with the expression of a splicing associated factor, Serine/arginine repetitive matrix 4 (SRRM4). Overexpressing SRRM4, known for regulating ME inclusion in mRNAs critical for neural differentiation, in human HEK293 cells resulted in the biogenesis of over 2000 novel ME-circRNAs, including ME-circEIF4G3, and changes in the abundance of many canonical circRNAs, including circSETDB2 and circLRBA. This shows SRRM4, in which its expression is correlated with poor prognosis in gliomas, acts as a bona fide circRNA biogenesis factor. Given the known roles of MEs and circRNAs in oncogenesis, the identification of these previously unrecognized ME-circRNAs further increases the complexity and functional purview of this non-coding RNA family.

1 September 2024 in Access Microbiology
Verified
Journal Article
Open access
AGAmy Louise Green
Amy Louise Green
DBDylan De Bellis
Dylan De Bellis
ECEvangeline Cowell
Evangeline Cowell
RLRoman V. Lenchine
Roman V. Lenchine
TPTimothy Penn
Timothy Penn
JCJillian M Carr
Jillian M Carr
The rat is a useful laboratory model for respiratory diseases. SARS-CoV-2 proteins, such as the spike (S) protein, can induce inflammation. This study has investigated the ability of the Q498Y, P499T (QP-YT) amino acid change, described in the S-protein of the mouse-adapted laboratory SARS-CoV-2 MA strain, to interact with rat angiotensin converting enzyme-2 (ACE2) and stimulate responses in rat lungs. A real-time S–ACE2 quantitative fusion assay shows that ancestral and L452R S-proteins fuse with human but not rat ACE2 expressed on HEK293 (human embryonic kidney-293) cells. The QP-YT S-protein retains the ability to fuse with human ACE2 and increases the binding to rat ACE2. Although lower lung of the rat contains both ACE2 and TMPRSS2 (transmembrane serine protease 2) target cells, intratracheal delivery of ancestral or QP-YT S-protein pseudotyped lentivirus did not induce measurable respiratory changes, inflammatory infiltration or innate mRNA responses. Isolation of primary cells from rat alveoli demonstrated the presence of cells expressing ACE2 and TMPRSS2. Infection of these cells, however, with ancestral or QP-YT S-protein pseudotyped lentivirus was not observed, and the QP-YT S-protein pseudotyped lentivirus poorly infected HEK293 cells expressing rat ACE2. Analysis of the amino acid changes across the S–ACE2 interface highlights not only the Y498 interaction with H353 as a likely facilitator of binding to rat ACE2 but also other amino acids that could improve this interaction. Thus, rat lungs contain cells expressing receptors for SARS-CoV-2, and the QP-YT S-protein variant can bind to rat ACE2, but this does not result in infection or stimulate responses in the lung. Further, amino acid changes in S-protein may enhance this interaction to improve the utility of the rat model for defining the role of the S-protein in driving lung inflammation.

23 December 2025 in bioRxiv
Verified
Preprint
Open access
DDD. DeBellis
D. DeBellis
TPT. Penn
T. Penn
ECEvangeline Cowell
Evangeline Cowell
MRMichael Roach
Michael Roach
LKL.P. Kris
L.P. Kris
JCJillian M Carr
Jillian M Carr
There is a need to understand pathogen driven lung disease and the rat is a laboratory model, widely used to study acute lung injury (ALI). Here the monocrotaline (MCT) rat has been investigated as a model of an inflammatory lung with developing pulmonary hypertension (PH) on which an ALI is superimposed. 14 days following a single systemic dose of MCT, the lung is functionally normal, but stimulation with lipopolysaccharide (LPS) results in an altered response. The MCT/LPS lung is morphologically similar to LPS alone, with respiratory mechanics showing increased elastance, reduced compliance and increased tissue resistance. Bronchioalveolar lavage (BAL) fluid demonstrated a cellular infiltrate, with large macrophage-like cells, increased secreted angiotensin converting enzyme-2 (ACE2) and total protein. The lung transcriptome is pushed towards a pro-inflammatory M1 phenotype, (interferon (IFN)-ϒ, interleukin 6 (IL6), CD68 and CD80) compared to LPS alone. Additionally, the MCT/LPS lung has gene transcription signatures for enhanced cell death and DNA damage responses, higher levels of multiple complement components, dysregulation of the renin-angiotensin pathway with reduced ACE2 and increased AGTR1, increased factors such as Erythroferrone that would increase iron levels, and increased fibrinogen and A2M, that would promote thrombosis. Thus, the MCT-treated rat represents an animal with no overt clinical distinction but following LPS stimulation elicits an exacerbated pathogenic lung response. The MCT-treated rat is a simple model that might be beneficial for understanding an M1 lung pathology with activated complement, low ACE2, high iron, and a propensity to clot in the context of developing cardiovascular disease.

4 September 2024
Verified
Preprint
Open access
AGAmy Louise Green
Amy Louise Green
DDDylan Debellis
Dylan Debellis
ECEvangeline Cowell
Evangeline Cowell
RLRoman V Lenchine
Roman V Lenchine
TPTimothy Penn
Timothy Penn
JCJillian M Carr
Jillian M Carr
The rat is a useful laboratory model for respiratory disease, and SARS-CoV-2 proteins such as the spike (S) protein can induce inflammation. This study has investigated the ability of the Q498Y, P499T (QP-YT) amino acid change described in the S-protein of the mouse adapted laboratory SARS-CoV-2 MA strain, to interact with rat angiotensin converting enzyme-2 (ACE2) and stimulate responses in rat lung. Using a real-time S-ACE2 quantitative fusion assay, ancestral and L452R S-protein fuses with human, but not rat ACE2 expressed on HEK293 cells. The QP-YT S-protein retains ability to fuse with human ACE2, and increases binding to rat ACE2. Although rat lower lung contains both ACE2 and TMPRSS2 target cells, intratracheal delivery of ancestral or QP-YT S-protein pseudotyped lentivirus did not induce measurable respiratory changes, inflammatory infiltration, or innate mRNA responses. Isolation of primary cells from rat alveoli demonstrated the presence of cells expressing ACE2 and TMPRSS2. Infection of these cells, however with ancestral or QP-YT S-protein pseudotyped lentivirus was not observed and the QP-YT S-protein pseudotyped lentivirus poorly infected HEK293 cells expressing rat ACE2. Analysis of the amino acid changes across the S-ACE2 interface highlights the Y498 interaction with H353 as a likely facilitator of binding to rat ACE2 but also other amino acids that could improve this interaction. Thus, rat lungs contain cells expressing receptors for SARS-CoV-2 and the QP-YT S-protein variant can bind to rat ACE2 but this does not result in infection or stimulate responses in the lung. Further amino acid changes in S-protein could enhance this interaction to improve the utility of the rat model for defining the role of the S-protein in driving lung inflammation.

7 May 2024
Verified
Preprint
Open access
AGAmy Louise Green
Amy Louise Green
DDDylan Debellis
Dylan Debellis
ECEvangeline Cowell
Evangeline Cowell
RLRoman Lenchine
Roman Lenchine
TPTimothy Penn
Timothy Penn
JCJillian M Carr
Jillian M Carr
The rat is a useful laboratory model for respiratory disease, and SARS-CoV-2 proteins such as the spike (S) protein can induce inflammation. This study has investigated the ability of the Q498Y, P499T (QP-YT) amino acid change described in the S-protein of the mouse adapted laboratory SARS-CoV-2 MA strain, to interact with rat angiotensin converting enzyme-2 (ACE2) and stimulate responses in rat lung. Using a real-time S-ACE2 quantitative fusion assay, ancestral S-protein fuses with human, but not rat ACE2. The QP-YT S-protein retains ability to fuse with human ACE2, and interacts with rat ACE2 in the fusion assay and using a S-protein pseudotyped lentivirus infection system. L452R S-protein did not bind to rat ACE2. Although rat lower lung contains both ACE2 and TMPRSS2 target cells, intratracheal delivery of ancestral or QP-YT S-protein pseudotyped lentivirus did not induce measurable respiratory changes, inflammatory infiltration, or innate mRNA responses. Isolation of primary cells from rat alveoli demonstrated the presence of cells expressing ACE2 and TMPRSS2. Infection of these cells, however with ancestral or QP-YT S-protein pseudotyped lentivirus was not observed. Analysis of the amino acid changes across the S-ACE2 interface highlights the Y498 interaction with H353 as a likely facilitator of binding to rat ACE2 but also other amino acids that could improve this interaction. Thus, rat lungs contain cells expressing receptors for SARS-CoV-2 and the QP-YT S-protein variant can bind to rat ACE2 but this does not result in infection or stimulate responses in the lung. Further amino acid changes in S-protein could enhance this interaction to improve the utility of the rat model for defining the role of the S-protein in driving inflammation in the lung.